In this episode, experts highlight the key takeaways from the Stand Up to Cancer SARC 032 study and its clinical implications.
Andrew Lim, MD
Advertisement
Andrew Lim, MD, is a radiation oncologist with Keck Medicine of USC.
Articles by Andrew Lim, MD
In this episode, experts discuss the landmark SARC 032 study, highlighting the importance of multidisciplinary collaboration.
In this episode, experts discuss the impact of neoadjuvant radiation and immunotherapy on surgical planning in patients with soft tissue sarcomas.
In this episode, experts shed light on the surgical approach to soft tissue sarcomas.
Moving the Needle in Undifferentiated Pleomorphic Sarcoma: Radiation Oncology and Immune Stimulation
In this episode, experts discuss the potential of radiation therapy to enhance immune response in soft tissue sarcomas.
In this episode, experts discuss the rationale behind the combined treatment in the Stand Up to Cancer SARC 032 trial.
In this episode, experts discuss the latest advancements in the multimodal treatment of undifferentiated pleomorphic sarcoma of the extremities.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
5